BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T163000
DTEND;TZID=America/New_York:20191104T190000
DTSTAMP:20191021T133736Z
CREATED:20191021T133736Z
LAST-MODIFIED:20191021T133736Z
UID:6886-1572885000-1572894000@scienceinboston.com
SUMMARY:Grand Opening: Ipsen Innovation Center / Biolabs
DESCRIPTION:Description\nOn Monday\, November 4\, 2019\, Ipsen invites you to join us as we celebrate the grand opening of the Ipsen Innovation Center | Biolabs. This event will offer an overview of our new collaborative space\, provide an opportunity to meet our resident companies\, and network with friends and colleagues from across the biotech community. \nLocated in Ipsen’s North American Global Hub in Kendall Square\, the Ipsen Innovation Center | Biolabs provides a collaborative space for early-stage life sciences entrepreneurs\, researchers and investors to develop and deliver new therapies for patients\, including those with cancer\, rare diseases and neurological disorders. The Innovation Center is already home to 11 companies with additional companies preparing to move in. \nTo learn more about Ipsen and its Business Development focus\, click here. \nIf you have any questions about the event\, please contact Nick Chang at nchang@macbiocom.com. \nSpace is limited.
URL:https://scienceinboston.com/event/grand-opening-ipsen-innovation-center-biolabs/
LOCATION:Ipsen Cambridge Office\, 650 Kendall St\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T163000
DTEND;TZID=America/New_York:20191104T190000
DTSTAMP:20191021T133736Z
CREATED:20191021T133736Z
LAST-MODIFIED:20191021T133736Z
UID:27351-1572885000-1572894000@scienceinboston.com
SUMMARY:Grand Opening: Ipsen Innovation Center / Biolabs
DESCRIPTION:Description\nOn Monday\, November 4\, 2019\, Ipsen invites you to join us as we celebrate the grand opening of the Ipsen Innovation Center | Biolabs. This event will offer an overview of our new collaborative space\, provide an opportunity to meet our resident companies\, and network with friends and colleagues from across the biotech community. \nLocated in Ipsen’s North American Global Hub in Kendall Square\, the Ipsen Innovation Center | Biolabs provides a collaborative space for early-stage life sciences entrepreneurs\, researchers and investors to develop and deliver new therapies for patients\, including those with cancer\, rare diseases and neurological disorders. The Innovation Center is already home to 11 companies with additional companies preparing to move in. \nTo learn more about Ipsen and its Business Development focus\, click here. \nIf you have any questions about the event\, please contact Nick Chang at nchang@macbiocom.com. \nSpace is limited.
URL:https://scienceinboston.com/event/grand-opening-ipsen-innovation-center-biolabs-2/
LOCATION:Ipsen Cambridge Office\, 650 Kendall St\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T103000
DTEND;TZID=America/New_York:20191104T160000
DTSTAMP:20191021T132702Z
CREATED:20191021T132702Z
LAST-MODIFIED:20191021T132702Z
UID:6883-1572863400-1572883200@scienceinboston.com
SUMMARY:Manufacturing Novel Biopharmaceuticals: 6 Keys to Success
DESCRIPTION:Overview\n\nCAI is passionate about helping development and clinical stage companies bring their product to market faster. Our custom solutions integrate the elements of product\, process\, quality\, facility\, and people to enable our clients achieve milestones quickly and reliably – while avoiding missteps that can impact patient access to novel\, life-saving therapies. \nWe welcome you to join our global team of experts to explore Manufacturing Novel Biopharmaceutical Products: Six Keys to Success on November 4th at MassBio in Kendall Square. \nMorning Session topics will include: \n\nQuality Systems: Early Adoption as a Competitive Advantage – John Henchion\nQuality by Design: Accelerating Patient Access to Novel Products – Jim Lambert\nFacility Design for Cell and Gene Therapy Products: Best Practices – Bill Deckert\n\nAfternoon Session topics will include \n\nProcess Validation:  Foundation for Product Lifecycle Management – Rusty Morrison\nTechnology Transfer Project Management Best Practices – Beth Haas\nTalent Plan: Growing the Team to Hit Each Milestone – Harry Benson\nPanel Discussion:  Speed to Market – Making it Happen – All speakers\, moderated by Charlie Maher\, Director Process and Manufacturing Technology\n\nCAI will host a networking lunch between sessions and an after-work reception at Catalyst from 4:00pm – 6:30pm. \nRSVP: https://caimassbio.eventbrite.com
URL:https://scienceinboston.com/event/manufacturing-novel-biopharmaceuticals-6-keys-to-success/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191104T103000
DTEND;TZID=America/New_York:20191104T160000
DTSTAMP:20191021T132702Z
CREATED:20191021T132702Z
LAST-MODIFIED:20191021T132702Z
UID:27350-1572863400-1572883200@scienceinboston.com
SUMMARY:Manufacturing Novel Biopharmaceuticals: 6 Keys to Success
DESCRIPTION:Overview\n\nCAI is passionate about helping development and clinical stage companies bring their product to market faster. Our custom solutions integrate the elements of product\, process\, quality\, facility\, and people to enable our clients achieve milestones quickly and reliably – while avoiding missteps that can impact patient access to novel\, life-saving therapies. \nWe welcome you to join our global team of experts to explore Manufacturing Novel Biopharmaceutical Products: Six Keys to Success on November 4th at MassBio in Kendall Square. \nMorning Session topics will include: \n\nQuality Systems: Early Adoption as a Competitive Advantage – John Henchion\nQuality by Design: Accelerating Patient Access to Novel Products – Jim Lambert\nFacility Design for Cell and Gene Therapy Products: Best Practices – Bill Deckert\n\nAfternoon Session topics will include \n\nProcess Validation:  Foundation for Product Lifecycle Management – Rusty Morrison\nTechnology Transfer Project Management Best Practices – Beth Haas\nTalent Plan: Growing the Team to Hit Each Milestone – Harry Benson\nPanel Discussion:  Speed to Market – Making it Happen – All speakers\, moderated by Charlie Maher\, Director Process and Manufacturing Technology\n\nCAI will host a networking lunch between sessions and an after-work reception at Catalyst from 4:00pm – 6:30pm. \nRSVP: https://caimassbio.eventbrite.com
URL:https://scienceinboston.com/event/manufacturing-novel-biopharmaceuticals-6-keys-to-success-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T113000
DTEND;TZID=America/New_York:20191103T120000
DTSTAMP:20191021T132418Z
CREATED:20191021T132418Z
LAST-MODIFIED:20191021T132418Z
UID:6879-1572780600-1572782400@scienceinboston.com
SUMMARY:PurpleStride Boston 2019: Walk with Elstar Therapeutics
DESCRIPTION:Overview\n\nElstar Therapeutics is proud to be a Silver Sponsor for this year’s PurpleStride in Boston. \nPancreatic cancer has the lowest survival rate of all major cancers\, at just 9%. This deadly disease has stolen our best and our brightest\, but it can’t take away our determination. \nOur team has stepped up to Wage Hope at PurpleStride\, the walk to end pancreatic cancer. Will you help us rewrite the future of this disease by making a donation today? \nEvery dollar that you donate ensures that the Pancreatic Cancer Action Network can continue working to create better outcomes for pancreatic cancer patients and their families. By donating to our team\, you are supporting vital efforts to double pancreatic cancer survival by 2020. \nPurple ribbons aren’t enough. Please join us in the fight today. 
URL:https://scienceinboston.com/event/purplestride-boston-2019-walk-with-elstar-therapeutics/
LOCATION:Boston Common – Parkman Bandstand\, 131 Tremont St\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T113000
DTEND;TZID=America/New_York:20191103T120000
DTSTAMP:20191021T132418Z
CREATED:20191021T132418Z
LAST-MODIFIED:20191021T132418Z
UID:27349-1572780600-1572782400@scienceinboston.com
SUMMARY:PurpleStride Boston 2019: Walk with Elstar Therapeutics
DESCRIPTION:Overview\n\nElstar Therapeutics is proud to be a Silver Sponsor for this year’s PurpleStride in Boston. \nPancreatic cancer has the lowest survival rate of all major cancers\, at just 9%. This deadly disease has stolen our best and our brightest\, but it can’t take away our determination. \nOur team has stepped up to Wage Hope at PurpleStride\, the walk to end pancreatic cancer. Will you help us rewrite the future of this disease by making a donation today? \nEvery dollar that you donate ensures that the Pancreatic Cancer Action Network can continue working to create better outcomes for pancreatic cancer patients and their families. By donating to our team\, you are supporting vital efforts to double pancreatic cancer survival by 2020. \nPurple ribbons aren’t enough. Please join us in the fight today. 
URL:https://scienceinboston.com/event/purplestride-boston-2019-walk-with-elstar-therapeutics-2/
LOCATION:Boston Common – Parkman Bandstand\, 131 Tremont St\, Boston\, MA\, 02111\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T083000
DTEND;TZID=America/New_York:20191101T180000
DTSTAMP:20191021T131835Z
CREATED:20191021T131835Z
LAST-MODIFIED:20191021T131835Z
UID:6872-1572597000-1572631200@scienceinboston.com
SUMMARY:Activated Egg Symposium
DESCRIPTION:The Bedford Research Foundation’s Activated Egg Symposium is a world-class lecture symposium featuring thought leaders from around the globe.  This years keynote speakers include: Dr. Joseph Takahashi\, Dr. Shoukhrat Mitalipov\, Dr. Ann A Kiessling and more.  A full lunch and dinner are provided as part of the registration\, the dinner speaker is renowned ethasist Arthur Applbaum.
URL:https://scienceinboston.com/event/activated-egg-symposium/
LOCATION:Marriot Courtyard Boston Downtown\, 275 Tremont St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T083000
DTEND;TZID=America/New_York:20191101T180000
DTSTAMP:20191021T131835Z
CREATED:20191021T131835Z
LAST-MODIFIED:20191021T131835Z
UID:27347-1572597000-1572631200@scienceinboston.com
SUMMARY:Activated Egg Symposium
DESCRIPTION:The Bedford Research Foundation’s Activated Egg Symposium is a world-class lecture symposium featuring thought leaders from around the globe.  This years keynote speakers include: Dr. Joseph Takahashi\, Dr. Shoukhrat Mitalipov\, Dr. Ann A Kiessling and more.  A full lunch and dinner are provided as part of the registration\, the dinner speaker is renowned ethasist Arthur Applbaum.
URL:https://scienceinboston.com/event/activated-egg-symposium-2/
LOCATION:Marriot Courtyard Boston Downtown\, 275 Tremont St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191021T131446Z
CREATED:20191021T131446Z
LAST-MODIFIED:20191021T131446Z
UID:6868-1572595200-1572627600@scienceinboston.com
SUMMARY:Questrom’s Seventh Annual Health & Life Sciences Conference
DESCRIPTION:The Health & Life Sciences Conference is an annual\, student-organized event that brings together a diverse audience of more than 250 students and professionals across all sectors of the US healthcare industry for valuable networking and comprehensive programming spanning healthcare delivery and hospitals\, to pharmaceuticals and medical devices. \n2019 Health & Life Science Conference  \nDisruption in the Face of Limitation:\nInnovation in an Era of Consumerism and Cost Sensitivity \nAs we approach 2020\, healthcare in the United States still occupies a large percentage of the United States Gross Domestic Product. Growing healthcare expenditures remain to be forecast for the coming years. With many industries embracing disruption through innovation\, can healthcare be targeted with initiatives to creatively decrease costs in the face of rising demand? At the 7th Annual Questrom Health & Life Sciences Conference\, panelists and speakers representing diverse stakeholders in the US healthcare system will engage in discussions around topics at the center of this drive to improve value so that we may begin to understand its impact\, both present and promised. \nTo show our appreciation\, our speakers from past years’ conferences are invited to attend this year’s conference as our guests! Please email buhlsc@bu.edu to receive a code for a complimentary conference ticket.
URL:https://scienceinboston.com/event/questroms-seventh-annual-health-life-sciences-conference/
LOCATION:Questrom School of Business\, 595 Commonwealth Ave\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191101T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191021T131446Z
CREATED:20191021T131446Z
LAST-MODIFIED:20191021T131446Z
UID:27346-1572595200-1572627600@scienceinboston.com
SUMMARY:Questrom’s Seventh Annual Health & Life Sciences Conference
DESCRIPTION:The Health & Life Sciences Conference is an annual\, student-organized event that brings together a diverse audience of more than 250 students and professionals across all sectors of the US healthcare industry for valuable networking and comprehensive programming spanning healthcare delivery and hospitals\, to pharmaceuticals and medical devices. \n2019 Health & Life Science Conference  \nDisruption in the Face of Limitation:\nInnovation in an Era of Consumerism and Cost Sensitivity \nAs we approach 2020\, healthcare in the United States still occupies a large percentage of the United States Gross Domestic Product. Growing healthcare expenditures remain to be forecast for the coming years. With many industries embracing disruption through innovation\, can healthcare be targeted with initiatives to creatively decrease costs in the face of rising demand? At the 7th Annual Questrom Health & Life Sciences Conference\, panelists and speakers representing diverse stakeholders in the US healthcare system will engage in discussions around topics at the center of this drive to improve value so that we may begin to understand its impact\, both present and promised. \nTo show our appreciation\, our speakers from past years’ conferences are invited to attend this year’s conference as our guests! Please email buhlsc@bu.edu to receive a code for a complimentary conference ticket.
URL:https://scienceinboston.com/event/questroms-seventh-annual-health-life-sciences-conference-2/
LOCATION:Questrom School of Business\, 595 Commonwealth Ave\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T180000
DTEND;TZID=America/New_York:20191030T210000
DTSTAMP:20191023T174535Z
CREATED:20191023T174535Z
LAST-MODIFIED:20191023T174535Z
UID:6971-1572458400-1572469200@scienceinboston.com
SUMMARY:Imagine & Believe An Evening to Benefit NTSAD
DESCRIPTION:Overview\n\nFor 62 years\, NTSAD has been bringing together families\, researchers\, clinicians and friends in the rare disease community to share\, learn\, network\, and collaborate with a goal of building relationships and identifying treatments and potential cures for Tay-Sachs\, Sandhoff\, Canavan\, and GM1 gangliosidosis. Vital to building this community is Imagine & Believe. Held annually\, the event draws honorees and special guests who embody the wisdom of the past challenges and the vision of the possibilities in rare disease research. In 2019\, we are thrilled to honor Cynthia Tifft\, MD\, PhD\, Deputy Clinical Director of the National Human Genome Research Institute/NIH\, who has championed natural history studies to build the framework of her just-announced GM1 clinical trials.  Dr. Tifft has been a partner and close friend to NTSAD and our families since 1998. \nThe goals of Imagine & Believe include (1) connecting leaders in research\, biotech\, medicine\, clinical pursuits\, science\, and our affected families with a goal of learning from the past\, discussing the current state of rare diseases\, and building alliances and partnerships for the future\, and (2) raising vital funds for continued research\, build and steward our veteran and new partnerships\, and serve our families. \nTraditionally\, about two-thirds of attendees are strongly networked in the biotech community\, especially in rare diseases.  Other attendees include family members\, clinicians\, scientists\, and special friends of NTSAD. \nThe evening program is as follows: \n6 – 7:30       Reception\, dinner & silent auction \n7:45 – 9pm  Dessert & program
URL:https://scienceinboston.com/event/imagine-believe-an-evening-to-benefit-ntsad/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T180000
DTEND;TZID=America/New_York:20191030T210000
DTSTAMP:20191023T174535Z
CREATED:20191023T174535Z
LAST-MODIFIED:20191023T174535Z
UID:27367-1572458400-1572469200@scienceinboston.com
SUMMARY:Imagine & Believe An Evening to Benefit NTSAD
DESCRIPTION:Overview\n\nFor 62 years\, NTSAD has been bringing together families\, researchers\, clinicians and friends in the rare disease community to share\, learn\, network\, and collaborate with a goal of building relationships and identifying treatments and potential cures for Tay-Sachs\, Sandhoff\, Canavan\, and GM1 gangliosidosis. Vital to building this community is Imagine & Believe. Held annually\, the event draws honorees and special guests who embody the wisdom of the past challenges and the vision of the possibilities in rare disease research. In 2019\, we are thrilled to honor Cynthia Tifft\, MD\, PhD\, Deputy Clinical Director of the National Human Genome Research Institute/NIH\, who has championed natural history studies to build the framework of her just-announced GM1 clinical trials.  Dr. Tifft has been a partner and close friend to NTSAD and our families since 1998. \nThe goals of Imagine & Believe include (1) connecting leaders in research\, biotech\, medicine\, clinical pursuits\, science\, and our affected families with a goal of learning from the past\, discussing the current state of rare diseases\, and building alliances and partnerships for the future\, and (2) raising vital funds for continued research\, build and steward our veteran and new partnerships\, and serve our families. \nTraditionally\, about two-thirds of attendees are strongly networked in the biotech community\, especially in rare diseases.  Other attendees include family members\, clinicians\, scientists\, and special friends of NTSAD. \nThe evening program is as follows: \n6 – 7:30       Reception\, dinner & silent auction \n7:45 – 9pm  Dessert & program
URL:https://scienceinboston.com/event/imagine-believe-an-evening-to-benefit-ntsad-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T083000
DTEND;TZID=America/New_York:20191030T190000
DTSTAMP:20191023T174345Z
CREATED:20191023T174345Z
LAST-MODIFIED:20191023T174345Z
UID:6968-1572424200-1572462000@scienceinboston.com
SUMMARY:Forsyth Symposium: Immune Modulation of the Host-Microbe Interface
DESCRIPTION:Join us for the second annual Forsyth Symposium: Immune Modulation at the Host-Microbe Interface \nWhen: 8:30 am – 7 pm\, October 30th\, 2019 \nWhere: Forsyth Institute\, 1 Athenaeum St\, Cambridge\, MA 02142 \nClick here for more information and to register
URL:https://scienceinboston.com/event/forsyth-symposium-immune-modulation-of-the-host-microbe-interface/
LOCATION:Forsyth Institute\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191030T083000
DTEND;TZID=America/New_York:20191030T190000
DTSTAMP:20191023T174345Z
CREATED:20191023T174345Z
LAST-MODIFIED:20191023T174345Z
UID:27366-1572424200-1572462000@scienceinboston.com
SUMMARY:Forsyth Symposium: Immune Modulation of the Host-Microbe Interface
DESCRIPTION:Join us for the second annual Forsyth Symposium: Immune Modulation at the Host-Microbe Interface \nWhen: 8:30 am – 7 pm\, October 30th\, 2019 \nWhere: Forsyth Institute\, 1 Athenaeum St\, Cambridge\, MA 02142 \nClick here for more information and to register
URL:https://scienceinboston.com/event/forsyth-symposium-immune-modulation-of-the-host-microbe-interface-2/
LOCATION:Forsyth Institute\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191029T120000
DTEND;TZID=America/New_York:20191029T160000
DTSTAMP:20191023T173626Z
CREATED:20191023T173626Z
LAST-MODIFIED:20191023T173626Z
UID:6966-1572350400-1572364800@scienceinboston.com
SUMMARY:Life Sciences & Biotech Internship and Job Career Fair
DESCRIPTION:Overview\n\nRegistration for the University of Massachusetts Amherst’s fall Life Sciences Career Fair is now open at this Handshake link.  The Fair will be held on Tuesday\, October 29\, 2019 from 12:00 – 4:00 pm in our Campus Center Auditorium.  Lunch\, parking and Wi-Fi access are all included.  Take $100 off the registration fee if you reserve and pay for your table before July 1\, 2019. \nCome meet with our large and diverse cohort of talented Life Sciences students (from undergraduates through PhD’s) for your internships\, co-ops\, fellowships and full time positions.  Last year\, we had over 600 students come to this Fair to network with the companies\, and learn more about the organizations\, and we anticipate more students this year. \nUMass Amherst students can now easily stay at our Mount Ida Campus in Newton\, when doing internships and co-ops in and around the Boston area. \nPlease let me know if you have any questions about this Career Fair\, Handshake\, or recruiting UMass Amherst students. \nJanet Bordwin \nDirector\, Career & Professional Development Center \nCollege of Natural Sciences \nUniversity of Massachusetts\, Amherst \njbordwin@umass.edu; 413-545-1545
URL:https://scienceinboston.com/event/life-sciences-biotech-internship-and-job-career-fair/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191029T120000
DTEND;TZID=America/New_York:20191029T160000
DTSTAMP:20191023T173626Z
CREATED:20191023T173626Z
LAST-MODIFIED:20191023T173626Z
UID:27365-1572350400-1572364800@scienceinboston.com
SUMMARY:Life Sciences & Biotech Internship and Job Career Fair
DESCRIPTION:Overview\n\nRegistration for the University of Massachusetts Amherst’s fall Life Sciences Career Fair is now open at this Handshake link.  The Fair will be held on Tuesday\, October 29\, 2019 from 12:00 – 4:00 pm in our Campus Center Auditorium.  Lunch\, parking and Wi-Fi access are all included.  Take $100 off the registration fee if you reserve and pay for your table before July 1\, 2019. \nCome meet with our large and diverse cohort of talented Life Sciences students (from undergraduates through PhD’s) for your internships\, co-ops\, fellowships and full time positions.  Last year\, we had over 600 students come to this Fair to network with the companies\, and learn more about the organizations\, and we anticipate more students this year. \nUMass Amherst students can now easily stay at our Mount Ida Campus in Newton\, when doing internships and co-ops in and around the Boston area. \nPlease let me know if you have any questions about this Career Fair\, Handshake\, or recruiting UMass Amherst students. \nJanet Bordwin \nDirector\, Career & Professional Development Center \nCollege of Natural Sciences \nUniversity of Massachusetts\, Amherst \njbordwin@umass.edu; 413-545-1545
URL:https://scienceinboston.com/event/life-sciences-biotech-internship-and-job-career-fair-2/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191028T080000
DTEND;TZID=America/New_York:20191029T170000
DTSTAMP:20191023T173318Z
CREATED:20191023T173318Z
LAST-MODIFIED:20191023T173318Z
UID:6963-1572249600-1572368400@scienceinboston.com
SUMMARY:FierceBiotech's 4th Drug Development Forum
DESCRIPTION:The 4th FierceBiotech Drug Development Forum\, taking place on October 28–29 in Boston\, provides a unique opportunity for attendees\, highlighting C-suite and executive leadership perspectives on how to successfully discover\, develop\, and commercialize a product. Our speaking faculty will also address key business considerations\, discussing how to map out the right financing strategy for your company and sharing strategies to mitigate risks and unlock the potential of acquisitions\, licensing deals\, and partnerships.
URL:https://scienceinboston.com/event/fiercebiotechs-4th-drug-development-forum/
LOCATION:The Colonnade Hotel\, 120 Huntington Avenue\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191028T080000
DTEND;TZID=America/New_York:20191029T170000
DTSTAMP:20191023T173318Z
CREATED:20191023T173318Z
LAST-MODIFIED:20191023T173318Z
UID:27364-1572249600-1572368400@scienceinboston.com
SUMMARY:FierceBiotech's 4th Drug Development Forum
DESCRIPTION:The 4th FierceBiotech Drug Development Forum\, taking place on October 28–29 in Boston\, provides a unique opportunity for attendees\, highlighting C-suite and executive leadership perspectives on how to successfully discover\, develop\, and commercialize a product. Our speaking faculty will also address key business considerations\, discussing how to map out the right financing strategy for your company and sharing strategies to mitigate risks and unlock the potential of acquisitions\, licensing deals\, and partnerships.
URL:https://scienceinboston.com/event/fiercebiotechs-4th-drug-development-forum-2/
LOCATION:The Colonnade Hotel\, 120 Huntington Avenue\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191027T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191023T172823Z
CREATED:20191023T172823Z
LAST-MODIFIED:20191023T172823Z
UID:6961-1572163200-1572627600@scienceinboston.com
SUMMARY:Leadership Strategies for Evolving Health Care Executives
DESCRIPTION:Overview\n\nHealth Care Executive Leadership Program Overview \nFocusing on management systems specific to health care\, this program provides skill building in the critical areas of leadership and management development. \nThe curriculum is designed to develop conflict resolution\, operational analysis\, employee management\, and quality management techniques necessary to achieve individual and organizational objectives. \nToday’s knowledge base is different from that of even six months ago\, and the solutions to tomorrow’s problems are within reach. \nAs a leader in the continuously evolving field of health care\, you have the formidable and immediate challenge of creating both short- and long-term strategies. This six-day program will enable you to respond proactively to the rapidly changing health care environment. \nProgram Benefits — Why You Should Participate \nGain insight into and develop the skills required to lead effectively in the dynamic and fast-changing field of health care. You will learn from distinguished Harvard faculty and network with professionals from prominent organizations. \nProgram Benefits \n\nSave money by knowing how to purchase services more effectively\nLearn how to decrease costly medical\, patient\, administrative\, and management errors\nBuild teams and processes to reduce redundancy; improving quality and reducing waste\nBenefit from consultant quality insight; improving productivity while increasing morale\n\nCourse Website
URL:https://scienceinboston.com/event/leadership-strategies-for-evolving-health-care-executives/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191027T080000
DTEND;TZID=America/New_York:20191101T170000
DTSTAMP:20191023T172823Z
CREATED:20191023T172823Z
LAST-MODIFIED:20191023T172823Z
UID:27363-1572163200-1572627600@scienceinboston.com
SUMMARY:Leadership Strategies for Evolving Health Care Executives
DESCRIPTION:Overview\n\nHealth Care Executive Leadership Program Overview \nFocusing on management systems specific to health care\, this program provides skill building in the critical areas of leadership and management development. \nThe curriculum is designed to develop conflict resolution\, operational analysis\, employee management\, and quality management techniques necessary to achieve individual and organizational objectives. \nToday’s knowledge base is different from that of even six months ago\, and the solutions to tomorrow’s problems are within reach. \nAs a leader in the continuously evolving field of health care\, you have the formidable and immediate challenge of creating both short- and long-term strategies. This six-day program will enable you to respond proactively to the rapidly changing health care environment. \nProgram Benefits — Why You Should Participate \nGain insight into and develop the skills required to lead effectively in the dynamic and fast-changing field of health care. You will learn from distinguished Harvard faculty and network with professionals from prominent organizations. \nProgram Benefits \n\nSave money by knowing how to purchase services more effectively\nLearn how to decrease costly medical\, patient\, administrative\, and management errors\nBuild teams and processes to reduce redundancy; improving quality and reducing waste\nBenefit from consultant quality insight; improving productivity while increasing morale\n\nCourse Website
URL:https://scienceinboston.com/event/leadership-strategies-for-evolving-health-care-executives-2/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191025T080000
DTEND;TZID=America/New_York:20191025T130000
DTSTAMP:20191023T171430Z
CREATED:20191023T170519Z
LAST-MODIFIED:20191023T171430Z
UID:6957-1571990400-1572008400@scienceinboston.com
SUMMARY:College & Career Exploration Day - Register to Volunteer
DESCRIPTION:Cambridge\, MA is the “hub” of the life sciences industry and provides many opportunities for students in the area to engage in career exploration experiences. MassBioEd recognizes that these same opportunities are not accessible to students in Western\, MA. College & Career Exploration Day allows these students to gain exposure to diverse fields of study and career options in many sectors of the life sciences. \nThis program is a one day event where 40+ volunteers from the life sciences industry mentor high school students through rapid-paced mentoring sessions. Students learn first-hand from industry volunteers about their unique qualifications\, educational backgrounds\, and interests that brought them to biotechnology and the contribution each of their roles make in this evolving industry. \nA mentor should be prepared to: \n\nProvide a brief presentation on what they do in the field\, for what organization\, and how that organization aspires to positively impact lives\,\nDiscuss the life sciences in general and share their own experiences within the field\,\nReflect on their personal journey and how they got to where they are today\,\nAllow time for questions from students\,\nProvide a demonstration or activity.\n\nThe BioTeach team is willing to provide volunteers with any feedback or ideas torwards their presentation and how to engage the students. \nSample Event Schedule: \n\n8:00 am: Registration\n9:00 am: Introduction/ Welcome Note\n9:30 am: Mentor Sessions/ Campus Tours\n11:00 am: Mentor Sessions/ Campus Tours\n12:20 pm: Lunch\n1:00 pm: Evaluations and Dismissal\n\nFor questions\, please contact Kretsy Mondesir at kretsy.mondesir@massbio.org or 617-674-5134.
URL:https://scienceinboston.com/event/college-career-exploration-day-register-to-volunteer/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191025T080000
DTEND;TZID=America/New_York:20191025T130000
DTSTAMP:20191023T170519Z
CREATED:20191023T170519Z
LAST-MODIFIED:20191023T170519Z
UID:27362-1571990400-1572008400@scienceinboston.com
SUMMARY:College & Career Exploration Day - Register to Volunteer
DESCRIPTION:Cambridge\, MA is the “hub” of the life sciences industry and provides many opportunities for students in the area to engage in career exploration experiences. MassBioEd recognizes that these same opportunities are not accessible to students in Western\, MA. College & Career Exploration Day allows these students to gain exposure to diverse fields of study and career options in many sectors of the life sciences. \nThis program is a one day event where 40+ volunteers from the life sciences industry mentor high school students through rapid-paced mentoring sessions. Students learn first-hand from industry volunteers about their unique qualifications\, educational backgrounds\, and interests that brought them to biotechnology and the contribution each of their roles make in this evolving industry. \nA mentor should be prepared to: \n\nProvide a brief presentation on what they do in the field\, for what organization\, and how that organization aspires to positively impact lives\,\nDiscuss the life sciences in general and share their own experiences within the field\,\nReflect on their personal journey and how they got to where they are today\,\nAllow time for questions from students\,\nProvide a demonstration or activity.\n\nThe BioTeach team is willing to provide volunteers with any feedback or ideas torwards their presentation and how to engage the students. \nSample Event Schedule: \n\n8:00 am: Registration\n9:00 am: Introduction/ Welcome Note\n9:30 am: Mentor Sessions/ Campus Tours\n11:00 am: Mentor Sessions/ Campus Tours\n12:20 pm: Lunch\n1:00 pm: Evaluations and Dismissal\n\nFor questions\, please contact Kretsy Mondesir at kretsy.mondesir@massbio.org or 617-674-5134.
URL:https://scienceinboston.com/event/college-career-exploration-day-register-to-volunteer-2/
LOCATION:Campus Center Auditorium\, UMass Amherst\, 1 Campus Center Way\, Amherst\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T160000
DTEND;TZID=America/New_York:20191024T170000
DTSTAMP:20191023T170138Z
CREATED:20191023T170138Z
LAST-MODIFIED:20191023T170138Z
UID:6954-1571932800-1571936400@scienceinboston.com
SUMMARY:The Future of CAR T Cell Therapy for Pediatric Leukemia
DESCRIPTION:Overview\n\nSPEAKER: Dr. Terry J. Fry\, M.D. \nSPEAKER BIO: Dr. Fry is a Professor of Pediatrics\, Hematology and Immunology\, Co-Director of the Human Immunology and Immunotherapy Initiative\, Director of Cancer Immunotherapy at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado.  He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia.  Prior to the NIH\, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington\, DC.  Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers.  He serves on the Committee for Scientific Affairs for the American Society of Hematology\, Vice Chair for Biology in the Cellular Therapy Committee of the Children’s Oncology Group and was recently elected into the American Society for Clinical Investigation. \nABSTRACT: Dr. Fry is an international expert in the development of cellular therapies for the management of children with cancer\, with an emphasis on acute leukemia.  He will present work from his laboratory that will inform translation of new cellular therapies into pediatric clinical trials.  He will also provide translational data that addresses the issue of duration of response and mechanism of resistance to cellular therapies. \nLIVE WEBCAST:  https://externalmediasite.partners.org/Mediasite/Play/a46012e230fe42229252e4275e05008d1d \nPARKING: Please park in the Yawkey Garage\, P3 or lower. Write “WS” on the back of your parking ticket and parking will be free upon your exit.
URL:https://scienceinboston.com/event/the-future-of-car-t-cell-therapy-for-pediatric-leukemia/
LOCATION:Dana Farber Cancer Institute\, 450 Brookline Avenue\, Yawkey Center for Cancer Care\, Lavine Family Dining Pavilion\, 3rd Floor\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T160000
DTEND;TZID=America/New_York:20191024T170000
DTSTAMP:20191023T170138Z
CREATED:20191023T170138Z
LAST-MODIFIED:20191023T170138Z
UID:27361-1571932800-1571936400@scienceinboston.com
SUMMARY:The Future of CAR T Cell Therapy for Pediatric Leukemia
DESCRIPTION:Overview\n\nSPEAKER: Dr. Terry J. Fry\, M.D. \nSPEAKER BIO: Dr. Fry is a Professor of Pediatrics\, Hematology and Immunology\, Co-Director of the Human Immunology and Immunotherapy Initiative\, Director of Cancer Immunotherapy at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado.  He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia.  Prior to the NIH\, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington\, DC.  Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers.  He serves on the Committee for Scientific Affairs for the American Society of Hematology\, Vice Chair for Biology in the Cellular Therapy Committee of the Children’s Oncology Group and was recently elected into the American Society for Clinical Investigation. \nABSTRACT: Dr. Fry is an international expert in the development of cellular therapies for the management of children with cancer\, with an emphasis on acute leukemia.  He will present work from his laboratory that will inform translation of new cellular therapies into pediatric clinical trials.  He will also provide translational data that addresses the issue of duration of response and mechanism of resistance to cellular therapies. \nLIVE WEBCAST:  https://externalmediasite.partners.org/Mediasite/Play/a46012e230fe42229252e4275e05008d1d \nPARKING: Please park in the Yawkey Garage\, P3 or lower. Write “WS” on the back of your parking ticket and parking will be free upon your exit.
URL:https://scienceinboston.com/event/the-future-of-car-t-cell-therapy-for-pediatric-leukemia-2/
LOCATION:Dana Farber Cancer Institute\, 450 Brookline Avenue\, Yawkey Center for Cancer Care\, Lavine Family Dining Pavilion\, 3rd Floor\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20191023T165052Z
CREATED:20191023T165052Z
LAST-MODIFIED:20191023T165052Z
UID:6952-1571905800-1571918400@scienceinboston.com
SUMMARY:MD Biosciences Symposium: Advances in Preclinical and Translational CNS Research
DESCRIPTION:Overview\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch clamp method for drug screening\n\n  \nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\n  \nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\n  \nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/md-biosciences-symposium-advances-in-preclinical-and-translational-cns-research/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20191023T165052Z
CREATED:20191023T165052Z
LAST-MODIFIED:20191023T165052Z
UID:27360-1571905800-1571918400@scienceinboston.com
SUMMARY:MD Biosciences Symposium: Advances in Preclinical and Translational CNS Research
DESCRIPTION:Overview\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch clamp method for drug screening\n\n  \nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\n  \nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\n  \nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/md-biosciences-symposium-advances-in-preclinical-and-translational-cns-research-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20190909T151923Z
CREATED:20190909T151923Z
LAST-MODIFIED:20190909T151923Z
UID:6457-1571905800-1571918400@scienceinboston.com
SUMMARY:Advances in Preclinical & Translational CNS Research - Cambridge\, MA
DESCRIPTION:MD Biosciences introduces novel models in neurophysiology and electrophysiology\, and translational pig models to advance CNS research.\n\n\n\n\n\n\nAbout this Event\n\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch Clamp method for drug screening\n\nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/advances-in-preclinical-translational-cns-research-cambridge-ma/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T083000
DTEND;TZID=America/New_York:20191024T120000
DTSTAMP:20190909T151923Z
CREATED:20190909T151923Z
LAST-MODIFIED:20190909T151923Z
UID:27340-1571905800-1571918400@scienceinboston.com
SUMMARY:Advances in Preclinical & Translational CNS Research - Cambridge\, MA
DESCRIPTION:MD Biosciences introduces novel models in neurophysiology and electrophysiology\, and translational pig models to advance CNS research.\n\n\n\n\n\n\nAbout this Event\n\n\nSymposium Overview \nSession I: Neurophysiology \n\n  Spinal cord injury in a dish\n  Synapse imaging: assessment of drug selection and efficacy\n  Histoneurology: IHC staining and analysis of neurological diseases\n  Patch Clamp method for drug screening\n\nSession II: Quantitative Output for Neurodegenerative Diseases Using in vivo Electrophysiology \n\nApplication of Electrophysiology as an endpoint in EAE Multiple Sclerosis studies\n\nSession III: Pig Models of Pain \n\nPost-operative pain\nModified post-operative pain\nNeuropathic pain\n\nMeet The Speakers \nSigal Meilin\, PhD\, Chief Scientific Officer \nDr. Meilin’s passion over 25 years has been in the understanding of neuro-degeneration and pain processes. Her research focus has been on exploring and creating true models of pain including translational models in pigs which closely mimic and forecast drug activity in humans. The MD Biosciences Innovalora laboratories\, under the scientific leadership of Sigal Meilin\, have become leaders in the discovery and validation of novel pathways and new candidate drugs. Sigal Meilin holds a PhD from Bar Ilan University in Tel Aviv\, Israel where she also continued her research involving multi-parametric monitoring of the living brain under oxygen stress and the cross talk between the immune system and the neuronal system in neurodegenerative disease. She was the leader of the pharmacology department of Pharmos\, Ltd\, prior to joining MD Biosciences in 2006. \nYoav Shulman\, PhD\, Neurophysiology Laboratory Manager \nDr. Shulman leads the neurophysiology and electrophysiology laboratories at MD Biosciences Innovalora. His primary focus is on method development and validation as well as execution of sponsor studies together with his team. Prior to joining MD Biosciences Innovalora\, Yoav completed his doctoral work at the Ben Gurion University of the Negev followed by a post-doctoral research at the Technion in Haifa\, Israel. Specialties include the establishment of spinal cord injury model using primary cultures from adult rat spine and peripheral nerve injury model using primary cultures from adult rat DRG. Other experiences include the establishment of an electrophysiology system for pharmacology assays using primary hippocampal cultures (Orenbuch et al. 2012)\, live Ca²ꜙ imaging and electrophysiology on ex-vivo brain slices (Sandler et al. 2016)\, live protein expression and movement\, identifying novel protein-protein interactions using a wide array of technologies (Shulman et al. 2015)\, Brain stem slices and electrophysiology measurements for ionic channel identification (Safori et al. 2015) and live EMPs\, SSEPs\, EEG and EMG for monitoring human brain and spine procedures in OR.
URL:https://scienceinboston.com/event/advances-in-preclinical-translational-cns-research-cambridge-ma-2/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191026T170000
DTSTAMP:20191023T164731Z
CREATED:20191023T162950Z
LAST-MODIFIED:20191023T164731Z
UID:6943-1571904000-1572109200@scienceinboston.com
SUMMARY:2019 Joslin International Symposium: Bioenergetics and its Dysregulation in Diabetes
DESCRIPTION:Overview\n\nJOSLIN INTERNATIONAL SYMPOSIUM \nBioenergetics and its Dysregulation in Diabetes \nHeld jointly with Banting & Best Diabetes Center\, Toronto and University of Copenhagen \n  \nOctober 24th-October 26th\, 2019 \nJoseph B. Martin Conference Center\nHarvard Medical School\n77 Avenue Louis Pasteur\nBoston MA\, 02115 \n  \nOrganizing Co-Chairs: \nRohit Kulkarni\, M.D.\, Ph.D. \nKeith Blackwell\, M.D.\, Ph.D. \n  \nHighlights will include: \n\n25 World Renowned Speakers\nEmphasis on Beta Cells to honor the contributions of Dr. Gordon Weir and Dr. Susan Bonner-Weir\n\n  \nFor more information\, please email: \ninternational.symposium@joslin.harvard.edu \n  \nOnline Registration: \njoslininternationalsymposium.cvent.com
URL:https://scienceinboston.com/event/2019-joslin-international-symposium-bioenergetics-and-its-dysregulation-in-diabetes/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191024T080000
DTEND;TZID=America/New_York:20191026T170000
DTSTAMP:20191023T162950Z
CREATED:20191023T162950Z
LAST-MODIFIED:20191023T162950Z
UID:27358-1571904000-1572109200@scienceinboston.com
SUMMARY:2019 Joslin International Symposium: Bioenergetics and its Dysregulation in Diabetes
DESCRIPTION:Overview\n\nJOSLIN INTERNATIONAL SYMPOSIUM \nBioenergetics and its Dysregulation in Diabetes \nHeld jointly with Banting & Best Diabetes Center\, Toronto and University of Copenhagen \n  \nOctober 24th-October 26th\, 2019 \nJoseph B. Martin Conference Center\nHarvard Medical School\n77 Avenue Louis Pasteur\nBoston MA\, 02115 \n  \nOrganizing Co-Chairs: \nRohit Kulkarni\, M.D.\, Ph.D. \nKeith Blackwell\, M.D.\, Ph.D. \n  \nHighlights will include: \n\n25 World Renowned Speakers\nEmphasis on Beta Cells to honor the contributions of Dr. Gordon Weir and Dr. Susan Bonner-Weir\n\n  \nFor more information\, please email: \ninternational.symposium@joslin.harvard.edu \n  \nOnline Registration: \njoslininternationalsymposium.cvent.com
URL:https://scienceinboston.com/event/2019-joslin-international-symposium-bioenergetics-and-its-dysregulation-in-diabetes-2/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
END:VCALENDAR